Abstract
Opsonins play a role in the hepatic uptake of particles such as bacteria, lipid emulsion, and liposomes. The objective of this study was to distinguish between opsonin depletion and uptake saturation in the dose-dependent hepatic uptake of liposomes. The uptake of opsonized and unopsonized liposomes was determined in the isolated perfused liver. Serum (2.9 mL) was required to opsonize 1 µmol liposomes fully, indicating that a rat (250 g with 10 mL of serum) can opsonize 3.5 µmol liposomes. Next the dose effect on hepatic uptake of opsonized and unopsonized liposomes was examined. Saturation of uptake was found only for the opsonized liposomes. On the other hand, the hepatic uptake clearance decreased dose dependently from 4.31 to 0.79 (mL/min), with increasing doses from 0.075 to 17 µmol/250 g, respectively, after i.v. administration. Thus, the decrease in the hepatic uptake clearance at the medium dose was due to the saturation of uptake alone, and at the high dose it was due to opsonin depletion as well. These results show that the saturation of liposomal uptake in the liver and the depletion of opsonins occurred at different liposome dosage levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
G. Gregoriadis and J. Senior. The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the ciruclation. FEBS Lett. 11943–11946 (1980).
H. H. Spanjer, M. van Galen, F. H. Roerdink, J. Regts, and G. L. Scherphof. Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition. Biochim. Biophys. Acta 863:224–230 (1986).
R. M. Abra and C. A. Hunt. Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim. Biophys. Acta 666:493–503 (1981).
P. L. Beaumier and K. J. Hwang. Effects of liposomes size on the degradation of bovine brain sphingomyelin/cholesterol liposomes in the mouse liver. Biochim. Biophys. Acta 731:23–30 (1983).
T. M. Allen and J. M. Everest. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. J. Pharm. Exp. Ther. 226:539–544 (1983).
M. E. Bosworth and C. A. Hunt. Liposome disposition in vivo. II. Dose dependency. J. Pharm. Sci. 71:100–104 (1982).
P. L. Beaumier, K. J. Hwang, and J. T. Slattery. Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from the circulation. Res. Comm. Chem. Path. Pharmacol. 39:277–289 (1983).
Y. Sato, H. Kiwada, and Y. Kato. Effects of dose and vesicle size on the pharmacokinetics of liposomes. Chem. Pharm. Bull. 34:4244–4252 (1986).
G. Gregoriadis. Fate of injected liposomes: Observations on entrapped solute retention, vesicle clearance and tissue distribution in vivo. In G. Gregoriadis (ed.), Liposomes as Drug Carriers, John Wiley & Sons, New York, 1988, pp. 3–18.
J. H. Senior. Fate and behavior of liposomes in vivo: A review of controlling factors. CRC Crit. Rev. Ther. Drug Carrier Syst. 3:123–193 (1987).
A. Gabizon and D. Papahadjopoulos. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 85:6949–6953 (1988).
E. Roerdink, J. Dijksra, G. Hartman, B. Bolscher, and G. Scherphof. The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Biochim. Biophys. Acta 677:79–89 (1981).
Y. E. Rahman, E. A. Cerny, K. R. Patel, E. H. Lau, and B. J. Wright. Differential uptake of liposomes varying in size and lipid composition by parenchymal and Kupffer cells of mouse liver. Life Sci. 31:2061–2071 (1982).
D. D. Chow, H. E. Essien, M. M. Padki, and K. J. Hwang. Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect. J. Pharm. Exp. Ther. 248:506–513 (1989).
Y. Kume, F. Maeda, H. Harashima, and H. Kiwada. Saturable, non-Michaelis-Menten uptake of liposomes by reticuloendothelial system. J. Pharm. Pharmacol. 43:162–166 (1991).
H. Harashima, Y. Kume, C. Yamane, and H. Kiwada. Non-Michaelis Menten type uptake of liposomes: Evidence for AUC or uptake amount dependency. J. Pharm. Pharmacol. 44:707–712 (1992).
C. J. van Oss, C. F. Gillman, P. M. Bronson, and J. R. Border. Opsonic properties of human serum alpha-2 HS glycoprotein. Imm. Com. 3:329–335 (1974).
J. Molnar, S. Mclain, C. Allen, H. Laga, A. Gara, and F. Gelder. The role of an alpha2-macroglobulin of rat serum in the phagocytosis of colloidal particles. Biochim. Biophys. Acta 493:37–54 (1977).
T. M. Saba, J. P. Filkins, and N. R. Di Luzio. Properties of the “opsonic system” regulating in vitro hepatic phagocytosis. J. Reticuloendothel. Soc. 3:398–414 (1966).
S. M. Moghimi and H. M. Patel. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett. 233:143–147 (1988).
S. D. Wright and P. A. Detmers. Receptor-mediated phagocytosis. In R. G. Crystal and J. B. West (eds.), The Lung, Raven Press, New York, 1991, pp. 539–551.
S. Miyauchi, Y. Sugiyama, Y. Sawada, K. Morita, T. Iga, and M. Hanano. Kinetics of hepatic transport of 4-methylumbeliferone in rats. Analysis by multiple indicator dilution method. J. Pharmacokin. Biopharm. 15:25–38 (1987).
K. Yamaoka, Y. Tanigawara, and T. Nakagawa. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharm. Dyn. 4:879–890 (1981).
R. L. Dedrick, D. S. Zaharko, and R. J. Lutz. Transport and binding of methotrexate in vivo. J. Pharm. Sci. 62:882–890 (1973).
S. Becker. Functions of the human mononuclear phagocyte system. Adv. Drug Del. Rev. 2:1–29 (1988).
S. M. Moghimi and H. Patel. Serum opsonins and phagocytosis of saturated and unsatruated phospholipid liposomes. Biochim. Biophys. Acta 984:384–387 (1989).
A. R. Nicholas and M. N. Jones. The effect of blood on the uptake of liposomal lipid by perfused rat liver. Biochim. Biophys. Acta 1074:105–111 (1991).
D. A. Tyrrell, V. J. Richardson, and B. E. Ryman. The effect of serum protein fractions on liposome-cell interactions in cultured cells and the perfused rat liver. Biochim. Biophys. Acta 497:469–480 (1977).
H. Kiwada, T. Miyajima, and Y. Kato. Studies on the uptake mechanism of liposomes by perfused rat liver. II. An indispensable factor for liver uptake in serum. Chem. Pharm. Bull. 35:1189–1195 (1987).
K. Funato, R. Yoda, and H. Kiwada. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim. Biophys. Acta 1103:198–204 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harashima, H., Sakata, K. & Kiwada, H. Distinction Between the Depletion of Opsonins and the Saturation of Uptake in the Dose-Dependent Hepatic Uptake of Liposomes. Pharm Res 10, 606–610 (1993). https://doi.org/10.1023/A:1018918623658
Issue Date:
DOI: https://doi.org/10.1023/A:1018918623658